634 related articles for article (PubMed ID: 30523619)
41. Plasma HHV-8 viral load in HHV-8-related lymphoproliferative disorders associated with HIV infection.
Simonelli C; Tedeschi R; Gloghini A; Talamini R; Bortolin MT; Berretta M; Spina M; Morassut S; Vaccher E; De Paoli P; Carbone A; Tirelli U
J Med Virol; 2009 May; 81(5):888-96. PubMed ID: 19319955
[TBL] [Abstract][Full Text] [Related]
42. Molecular Biology of KSHV in Relation to HIV/AIDS-Associated Oncogenesis.
He M; Cheng F; da Silva SR; Tan B; Sorel O; Gruffaz M; Li T; Gao SJ
Cancer Treat Res; 2019; 177():23-62. PubMed ID: 30523620
[TBL] [Abstract][Full Text] [Related]
43. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
Cheung MC; Pantanowitz L; Dezube BJ
Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
[TBL] [Abstract][Full Text] [Related]
44. Malignancy Trends in HIV-Infected Patients Over the Past 10 Years in a Single-Center Retrospective Observational Study in the United States.
Rihana N; Nanjappa S; Sullivan C; Velez AP; Tienchai N; Greene JN
Cancer Control; 2018; 25(1):1073274818797955. PubMed ID: 30185062
[TBL] [Abstract][Full Text] [Related]
45. Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases.
Rezza G; Andreoni M; Dorrucci M; Pezzotti P; Monini P; Zerboni R; Salassa B; Colangeli V; Sarmati L; Nicastri E; Barbanera M; Pristerà R; Aiuti F; Ortona L; Ensoli B
J Natl Cancer Inst; 1999 Sep; 91(17):1468-74. PubMed ID: 10469747
[TBL] [Abstract][Full Text] [Related]
46. Prevention of Oncogenic
Atamna A; Yahav D; Hirzel C
Transpl Int; 2023; 36():11856. PubMed ID: 38046068
[TBL] [Abstract][Full Text] [Related]
47. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
Bonnet F; Lewden C; May T; Heripret L; Jougla E; Bevilacqua S; Costagliola D; Salmon D; Chêne G; Morlat P
Cancer; 2004 Jul; 101(2):317-24. PubMed ID: 15241829
[TBL] [Abstract][Full Text] [Related]
48. Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007.
Seaberg EC; Wiley D; Martínez-Maza O; Chmiel JS; Kingsley L; Tang Y; Margolick JB; Jacobson LP;
Cancer; 2010 Dec; 116(23):5507-16. PubMed ID: 20672354
[TBL] [Abstract][Full Text] [Related]
49. Kaposi sarcoma-associated herpesvirus (human herpesvirus type 8)-associated extracavitary lymphoma: Report of a case in an HIV-positive patient with simultaneous kaposi sarcoma and a review of the literature.
Zhang H; Yang XY; Hong T; Feldman T; Bhattacharyya PK
Acta Haematol; 2010; 123(4):237-41. PubMed ID: 20484888
[TBL] [Abstract][Full Text] [Related]
50. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 May; 16(5):657-65; discussion 665, 668-70. PubMed ID: 12108891
[TBL] [Abstract][Full Text] [Related]
51. Human herpesvirus 8 DNA in CNS lymphomas from patients with and without AIDS.
Corboy JR; Garl PJ; Kleinschmidt-DeMasters BK
Neurology; 1998 Feb; 50(2):335-40. PubMed ID: 9484350
[TBL] [Abstract][Full Text] [Related]
52. Kaposi sarcoma-associated herpesvirus-associated malignancies: epidemiology, pathogenesis, and advances in treatment.
Bhutani M; Polizzotto MN; Uldrick TS; Yarchoan R
Semin Oncol; 2015 Apr; 42(2):223-46. PubMed ID: 25843728
[TBL] [Abstract][Full Text] [Related]
53. Direct Epstein-Barr virus (EBV) typing on peripheral blood mononuclear cells: no association between EBV type 2 infection or superinfection and the development of acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma.
van Baarle D; Hovenkamp E; Kersten MJ; Klein MR; Miedema F; van Oers MH
Blood; 1999 Jun; 93(11):3949-55. PubMed ID: 10339504
[TBL] [Abstract][Full Text] [Related]
54. Human immunodeficiency virus/acquired immunodeficiency syndrome and cancer: past, present, and future.
Engels EA; Goedert JJ
J Natl Cancer Inst; 2005 Mar; 97(6):407-9. PubMed ID: 15769998
[No Abstract] [Full Text] [Related]
55. Oncological problems in AIDS--a review of the clinical features and management.
Geh JI; Spittle MF
Ann Acad Med Singap; 1996 May; 25(3):380-91. PubMed ID: 8876905
[TBL] [Abstract][Full Text] [Related]
56. Oral manifestations of recently described viral infections, including AIDS.
Reichart PA
Curr Opin Dent; 1991 Aug; 1(4):377-83. PubMed ID: 1666307
[TBL] [Abstract][Full Text] [Related]
57. Primary effusion lymphoma presenting as a cutaneous intravascular lymphoma.
Crane GM; Xian RR; Burns KH; Borowitz MJ; Duffield AS; Taube JM
J Cutan Pathol; 2014 Dec; 41(12):928-35. PubMed ID: 25355615
[TBL] [Abstract][Full Text] [Related]
58. Lymphomas occurring specifically in HIV-infected patients: from pathogenesis to pathology.
Gloghini A; Dolcetti R; Carbone A
Semin Cancer Biol; 2013 Dec; 23(6):457-67. PubMed ID: 23999127
[TBL] [Abstract][Full Text] [Related]
59. Current perspectives on the molecular pathogenesis of virus-induced cancers in human immunodeficiency virus infection and acquired immunodeficiency syndrome.
Kieff E
J Natl Cancer Inst Monogr; 1998; (23):7-14. PubMed ID: 9709295
[TBL] [Abstract][Full Text] [Related]
60. Viruses as potential targets for therapy in HIV-associated malignancies.
Ambinder RF
Hematol Oncol Clin North Am; 2003 Jun; 17(3):697-702, v-vi. PubMed ID: 12852651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
